Skip to content
Skip to menu
Home
Contact
Subscribe to newsfeed
Sitemap
IDF 2009 Montreal
International Diabetes Foundation
Congress Info
Registrations
Programme
Accommodation and Travel
Sponsorship
Contact Us
POSTER PRESENTATIONS OVERVIEW
Show data as:
List view
Date:
Monday - Tuesday
Wednesday - Thursday
Stream:
Association Development
Clinical Research
Education
Foundation Science
Healthcare and Epidemiology
Living with Diabetes
Session Format:
Poster Presentation
Topic:
Abbott Diabetes Care
Access to drugs and technologies
Addressing psychosocial issues
Addressing psychosocial issues in diabetes education
Adequate nutrition: prenatal and postnatal – vital
Adult and youth empowerment
Aetiology of type 2 diabetes - genetics vs environment
Alternative medicine
Alternative medicine: its role and practice
Alternative therapies: efficacy metabolism, trials
An evening with the President and IDF
Animal models of diabetes
Are the highly academic clinical guidelines useful to the patient on the ground?
Aspects in industry-association interactions
Assessment of cardiovascular risk in type 2 diabetes
Association and governments: interaction and co-operation
Association development in the context of IDF
Association-based initiatives to improve diabetes-related care
Association-government interaction: how to go about it!
Associations and relationships with industry
Astra Zeneca/Bristol-Myers Squibb Alliance
AstraZeneca/Bristol-Myers Squibb Alliance: The Struggling Patient: Optimizing Oral Glycaemic Therapy in Type 2 Diabetes
Awareness and education through skits/song/dance/mime
Bayer Diabetes Care: Improving patient outcomes in diabetes: Innovative why's and how's of diabetes management
Bayer Schering Pharma: Diabetes, Prediabetes and CVD - the Need for Early Intervention
Beta cell mass in the pathogenesis of type 2 diabetes: is it the critical component?
Beta cells: from origin to dysfunction and death
Biochemical complications
Blood lipids and lipoproteins
Blood pressure
Blood pressure management in diabetes
Camping: positives and negatives
Cardiometabolic risk
Care of the elderly
Celebrating diabetes
Central regulation of food intake and metabolism
Clinical care improving outcomes
Clinical outcomes and nutritional intake
Cohort populations and use of databases
Cohort studies
Colgate: Oral complications in management of diabetes
Complementary medicines: is there a place in diabetes?
Complications - biochemical mechanisms
Complications - cardiovascular disease
Complications - dyslipidemia
Complications - eye
Complications - eye
Complications - foot
Complications - hypertension
Complications - kidney
Complications - macrovascular
Complications - macrovascular 1
Complications - macrovascular 2
Complications - macrovascular 3
Complications - macrovascular 4
Complications - macrovascular 5
Complications - macrovascular 6
Complications - nephropathy 1
Complications - nephropathy 2
Complications - nerve
Complications - neuropathy
Complications - neuropathy 1
Complications - neuropathy 2
Complications - prediction of mortality and cardiovascular events
Dealing with diabetes through narration
Developing innovative educational materials and programmes for parents and young people with type 1 diabetes
Diabète Québec: Epidémie, Prévention et Prise en charge du diabète
Diabetes and disasters: natural and man-made
Diabetes and hyperglycaemia: the size of the problem
Diabetes and infections
Diabetes and obesity management: fat distribution, bariatric surgery, obesity drugs as glucose-lowering drugs, appetite control in diabetes
Diabetes and obesity-predisposing genes
Diabetes and the brain
Diabetes associations
Diabetes care and disasters
Diabetes care to the people: what is the role of IDF Guidelines?
Diabetes education delivery
Diabetes education in childhood and adolescence
Diabetes in children
Diabetes in indigenous communities
Diabetes in indigenous populations
Diabetes in the young
Diabetes online
Diabetes therapy
Diabetes x 4 - it's just a way of life
Diabetes Youth Empowerment Programme: its value and place in the future of IDF
Diabetes: invest in prevention or early diagnosis ?
Diagnosis and classification
Discrimination and diabetes
Economics of diabetes
Ectopic fat and cardiometabolic risk in type 2 diabetes - EAS/ICCR joint symposium
Education initiatives
Effective education: process and outcome
Eli Lilly and Company: Treatment Choices, Education and Your Patient with Type 2 Diabetes
Empowering associations to overcome local problems
Empowering youth with diabetes
Epidemiology
Epidemiology
Establishing diabetes education in emerging countries
Exercise and insulin sensitivity: mechanisms and potential
Exercise in prevention and management
Experience with alternative therapies
Experimental approaches to the treatment of type 1 diabetes
Extrapancreatic effects of the incretins
First line combination therapy for type 2 diabetes
Food and diabetes: what's the fuss?
Foot care
Foot care 1
Foot care 2
Foot care 3
From professional and peer education to diabetes self-management
From theory to practice: a presentation of three translational research projects supported by IDF BRIDGES
From yesterday to tomorrow: making a difference to global diabetes
Future of type 1 diabetes: does technology hold the key?
General assembly Europe (part 2)
General Assembly Europe (Part 3)
General assembly Europe (part1)
Generation of islet ß-cells from stem cells
Genetic regulation of islet ß-cell function and survival
Genetics of diabetes
Genetics of type 1 diabetes
Genetics of type 2 diabetes
Genetics of type 2 diabetes - relevance to clinical practice
Genome-wide association scans for obesity and diabetes
Gestational diabetes
Glucagon physiology and pathophysiology
Glucose variability: does it make a difference ?
Glucose-lowering drugs and cancer
Glucose-lowering for the prevention of cardiovascular disease: positive, negative or neutral?
Glycaemic control
Glycated haemoglobin
Grant-writing for translational research
Guidelines, clinical care
Guidelines, clinical care
Health literacy: what is its implication for education?
Healthy lifestyle - diet vs exercise
HIV therapy and diabetes risk
How can we help our patients reduce hypoglycaemia unawareness?
How does culture impact on diabetes education?
Hypoglycaemia - causes and solutions
Hypoglycaemia in diabetes
IDF and the associations; but what of the individual with diabetes?
IDF and the UN Resolution
IDF Diabetes Atlas Press Conference and global Teleconference
IDF global diabetes education activities
IDF Global Education Agenda Press Conference
IDF Global Guidelines Press Conference and Teleconference
IDF Impact Study Results Press Conference
IDF SACA Bernard Houssay Memorial Lecture
IDF through the decades: have we met our aims?
Improving effectiveness of diabetes education
Improving wider aspects of the management of type 1 diabetes
In-hospital glycaemic management of diabetes
In-patient care
Incretin therapies
Incretin therapies
Incretin therapies in clinical practice
Indigenous communities and ethnicity issues
Indigenous populations
Inflammation and diabetes
Inflammation and diabetes
Inflammation and diabetes
Initiate a behavioural change in three minutes – break the barriers!
Initiatives which could be of help to other associations
Innovations and application of IT to diabetes education
Innovative education tools and IT application to diabetes education
Insulin action
Insulin action - carbohydrate, lipid and protein metabolism
Insulin action - glucose transport, receptors, cellular mechanisms
Insulin for all: can we make it a reality?
Insulin insensitivity and the metabolic syndrome
Insulin insensitivity and the metabolic syndrome
Insulin resistance, islet ß-cells and mitochondrial dysfunction
Insulin secretion and signal transduction
Insulin secretion, dysfunction and the islet ß-cell
Insulin signalling - where and how to study it?
Insulin therapy
Insulin therapy and devices
Intensifying Expectations: Assessing Unmet Needs in Diabetes Management
Intensive glucose control in the critically ill
Interaction of aetiological factors in type 2 diabetes - key to prevention?
International Diabetes Federation/Canadian Diabetes Association: Celebretion of Diabetes Education
International diabetes management practices study (IDMPS)
Intervention for prevention of type 2 diabetes: periodical or lifetime?
Introduction to IDF Diabetes Impact Studies
Is anti-obesity drug treatment appropriate for treatment of obese patients with type 2 diabetes?
Is prevention feasible ?
Is self-monitoring useful in type 2 diabetes: what is the evidence? in whom?
Islets - beta cell damage and apoptosis
Islets - insulin secretion and signal transduction
ISPAD Lecture
Kathmandu Declaration: UNR implementation of prevention strategies
Late-breaking abstracts
Late-breaking abstracts session
Latest clinical trials
Life for a Child Program documentary
Lifestyle initiatives
Lifestyle issues in self-management
Living with diabetes
Living with diabetes and its complications: perspective of someone with diabetes
Living with diabetes: a family approach
Living with someone with diabetes: challenges and solutions
Management of prediabetes and type 2 diabetes in adolescence
Managing older people with diabetes more effectively - avoiding pitfalls and rejecting some common beliefs
Mechanism of obesity
Media, and public awareness
Medical treatment of diabetic eye disease
Meet the President Press Briefing
Merck Sharp & Dome: Achieving early & effective glycemic control: the role of sitagliptin in the treatment of type 2 diabetes
Models of care delivery
Models of diabetes care from around the world
Molecular regulation of the ß-cell function and survival
Monitoring of blood glucose control
Munich Diabetes Research Institute: Diabetes and the Heart: State-of-the-art treatment strategies
Music as a medium of communication
National and local plans and initiatives
National plans to optimize diabetes care
New IDF diabetes guidelines
New technologies in the management of diabetes
Non-type 1 diabetes in children
Normal and pathological insulin signalling
Novel approaches in diabetes education
Novel therapeutic approaches to prevention and management of type 1 diabetes
Novel therapies for glucose-lowering
Novo Nordisk: Changing the course of diabetes with modern treatments
Nutrition and diet
Nutrition and its effects on metabolism
Nutrition guidelines: challenges and solutions
Obesity: weight regulation, prevention, management, pathophysiology
Oral agents in type 2 diabetes (1)
Oral agents in type 2 diabetes (2)
Oral glucose-lowering therapies
Pathogenesis and novel therapies for type 1 diabetes
Pathophysiology of obesity
Patient empowerment and self-management
Peer and rural education
Peer education
Physical activity and diabetes: what to prescribe, why and how?
Physical activity and exercise
Physical activity and exercise
Populations at risk: understanding why
PPAR-agonists 10 years on
Prediabetes: which organ is the culprit?
Pregnancy and gestational diabetes
Pregnancy and gestational diabetes
Pregnancy: epidemiology, outcomes and management
Preventing the development of diabetes
Prevention initiatives for type 1 diabetes and type 2 diabetes
Prevention of type 2 diabetes and CVD: diabesity
Primary prevention
Primary prevention of type 2 diabetes
Primary prevention of type 2 diabetes: drugs vs lifestyle
Primary prevention programmes for diabetes: lifestyle vs drugs
Professional and peer education
Programmes for secondary prevention of complications
Psychological stress: cause and effect
Psychosocial / behavioural interventions
Psychosocial and behavioural interventions
Psychosocial issues and lifestyle
Psychosocial problems and diabetes
Quality assurance and clinical application of guidelines
Quality assurance in diabetes care
Redefining diabetes? what tools? what is it anyway?
ResMed: Wake up to sleep apnoea and diabetes
Revising the diagnostic criteria for diabetes; the 2009 WHO/IDF initiatives
Roche: Structured SMBG and new therapeutic strategies to improve glycemic control in Type 2 diabetes patients not using insulin
Role of associations in different environments
sanofi-aventis Groupe: Approaching a century of insulin therapy: key learnings
Screening
Screening
Screening for diabetes: moving to reality?
Screening for type 2 diabetes
Secondary diabetes
Secondary prevention programmes for prevention of complications
Self-monitoring
Self-monitoring and awareness programs
SERVIER: Diabetes complications: from early kidney injury to management of cardiovascular disease
Setting up national health programmes
Socratic dialogue: patient empowerment
Solvay Pharmaceuticals: T2 diabetic patients, Go beyond the statin quo
State of diabetes associations around the world
Statistical interpretation of clinical trials in diabetes
Strengthening structure and communications within IDF
Stress: the critical factor in type 2 diabetes?
Successful models of intervention from around the world
T-fal Cooking Demonstration
Takeda: Adressing Type 2 Diabetes as its Core: Disease-Modifying Therapies Applied
The associations should take the lead in offering diabetes care
The diabetic foot updated
The foot in diabetes: collaborations to improve care
The Global Partnership for Effective Diabetes Management: Taking evidence into the clinic: practical guidance to improving diabetes care
The relationships between IDF and diabetes associations
The renin angiotensin system in diabetes: from islet to kidney
The role of endoplasmic reticulum stress in diabetes
TIDES: being prepared for an emergency
To vitamin D or not to vitamin D: a question on the aetiology of type 1 diabetes
Traditional medicines in diabetes care
Training foot care assistants in Jamaica and the Caribbean
Transitional care - adolescence to adulthood
Turning diabetes to my advantage
Twinning and the Mozambique experience
Twinning: a way forward for association development ?
Type 1 diabetes: from pathogenesis to intervention trials
UN/UNESCO Helmut Mehnert Award Lecture
United we stand - a global diabetes strategy
What is obesity and why?
Where now for diabetes genetics?
Which are the in vivo sources of ß-cells ?
Which will be the best alternatives to replace the lost ß-cells in diabetes?
World Diabetes Congress Opening Press Conference
Worldwide Initiative for Diabetes Education : Optimiser le contrôle de la glycémie et des autres facteurs de risque à long terme dans le diabète de type 2
Keyword:
Author name: